71 related articles for article (PubMed ID: 26281211)
1. [THE INDUCTION OF CD25 EXPRESSION IN Jurkat T CELLS].
Shatrova AN; Mityushova EV; Aksenov NV; Marakhova LL
Tsitologiia; 2015; 57(5):345-52. PubMed ID: 26281211
[TBL] [Abstract][Full Text] [Related]
2. [The surface expression of CD25 at different stages of proliferative response in human lymphocytes. II. The role of interleukin-2].
Shatrova AN; Zenin VV; Aksenov ND; Mitiushova EV; Marakhova II
Tsitologiia; 2011; 53(8):652-8. PubMed ID: 21961284
[TBL] [Abstract][Full Text] [Related]
3. Time-Dependent Regulation of IL-2R α-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes.
Shatrova AN; Mityushova EV; Vassilieva IO; Aksenov ND; Zenin VV; Nikolsky NN; Marakhova II
PLoS One; 2016; 11(12):e0167215. PubMed ID: 27936140
[TBL] [Abstract][Full Text] [Related]
4. [The surface expression of CD25 at different stages of proliferative response in human lymphocytes. I. The role of JAK and Src tyrosine kinases as revealed by inhibitory analysis].
Zenin VV; Aksenov ND; Shatrova AN; Mitiushova EV; Marakhova II
Tsitologiia; 2011; 53(8):645-51. PubMed ID: 21961283
[TBL] [Abstract][Full Text] [Related]
5. [The STAT5 signaling in the expression of alpha-subunit of interleukin-2 receptor in human blood lymphocytes].
Mitiushova EV; Shatrova AN; Zenin VV; Aksenov ND; Marakhova II
Tsitologiia; 2013; 55(6):421-9. PubMed ID: 25509109
[TBL] [Abstract][Full Text] [Related]
6. [The expression of CD25 in phytohemagglutinin- or interleukin-2-stimulated human peripheral blood lymphocytes].
Zenin VV; Aksenov ND; Shatrova AN; Marakhova II
Tsitologiia; 2009; 51(6):506-10. PubMed ID: 19637754
[TBL] [Abstract][Full Text] [Related]
7. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
[TBL] [Abstract][Full Text] [Related]
8. [Specific function of STAT5 in regulation of proliferation of chronic leukemia K562 cells: inhibitory effect of WHI-P131].
Mitiushova EV; Aksenov ND; Marakhova II
Tsitologiia; 2010; 52(2):184-90. PubMed ID: 20352702
[TBL] [Abstract][Full Text] [Related]
9. The molecular mechanism of curcumol on inducing cell growth arrest and apoptosis in Jurkat cells, a model of CD4⁺ T cells.
Wang H; Wang Y; Jiang X; Wang Z; Zhong B; Fang Y
Int Immunopharmacol; 2014 Aug; 21(2):375-82. PubMed ID: 24877754
[TBL] [Abstract][Full Text] [Related]
10. Ionomycin inhibits Jurkat T cell behaviors in the presence of phorbol-12,13-dibutyrate.
Wang Y; Hao W; Xing R; Di J; Zeng S; Liu J; Xing F
Ann Hematol; 2014 May; 93(5):735-46. PubMed ID: 24292536
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of the functional expression of the Na/K-pump in human lymphocytes, activated by phytohemagglutinin, phorbol ester, ionomycin, and interleukin-2].
Toropova FV; Vinogradova TA; Marakhova II
Tsitologiia; 2001; 43(2):148-55. PubMed ID: 11347470
[TBL] [Abstract][Full Text] [Related]
12. Piperine blocks interleukin-2-driven cell cycle progression in CTLL-2 T lymphocytes by inhibiting multiple signal transduction pathways.
Doucette CD; Greenshields AL; Liwski RS; Hoskin DW
Toxicol Lett; 2015 Apr; 234(1):1-12. PubMed ID: 25655587
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat by a novel peptide inhibitor of protein kinase C.
Ioannides CG; Freedman RS; Liskamp RM; Ward NE; O'Brian CA
Cell Immunol; 1990 Nov; 131(1):242-52. PubMed ID: 2121373
[TBL] [Abstract][Full Text] [Related]
14. [Activation of transcriptional factors stat5 and stat3 during human T-lymphocyte proliferation induced by different mitogenic stimuli].
Karitskaia IA; Aksenov ND; Zenin VV; Khaĭdukova AL; Marakhova II
Tsitologiia; 2006; 48(1):42-9. PubMed ID: 16568834
[TBL] [Abstract][Full Text] [Related]
15. Arecoline inhibits interleukin-2 secretion in Jurkat cells by decreasing the expression of alpha7-nicotinic acetylcholine receptors and prostaglandin E2.
Hwang GS; Hu S; Lin YH; Chen ST; Tang TK; Wang PS; Wang SW
J Physiol Pharmacol; 2013 Oct; 64(5):535-43. PubMed ID: 24304567
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of berberine on the activation and cell cycle progression of human peripheral lymphocytes.
Xu L; Liu Y; He X
Cell Mol Immunol; 2005 Aug; 2(4):295-300. PubMed ID: 16274628
[TBL] [Abstract][Full Text] [Related]
17. Phosphospecific flow cytometry for pharmacodynamic drug monitoring: analysis of the JAK-STAT signaling pathway.
Vafadari R; Weimar W; Baan CC
Clin Chim Acta; 2012 Sep; 413(17-18):1398-405. PubMed ID: 22261016
[TBL] [Abstract][Full Text] [Related]
18. Cot kinase regulation of IL-2 production in Jurkat T cells.
Ballester A; Tobeña R; Lisbona C; Calvo V; Alemany S
J Immunol; 1997 Aug; 159(4):1613-8. PubMed ID: 9257820
[TBL] [Abstract][Full Text] [Related]
19. Quantitative and qualitative signals determine T-cell cycle entry and progression.
Modiano JF; Mayor J; Ball C; Chitko-McKown CG; Sakata N; Domenico-Hahn J; Lucas JJ; Gelfand EW
Cell Immunol; 1999 Oct; 197(1):19-29. PubMed ID: 10555992
[TBL] [Abstract][Full Text] [Related]
20. [Inhibitor of tyrosine phosphorylation AG490 inhibits the proliferation of Jurkat T cells].
Mao CQ; Xing FY; Guo ZF; Fang ZY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Mar; 26(3):214-7. PubMed ID: 20230682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
